In breast cancer, 17β-estradiol (E2)-ER signaling regulates critical functional properties, such as cell differentiation, proliferation, epithelial-to-mesenchymal transition (EMT), migration, invasion, metastasis, and resistance to treatment. This evidence concerns the gene ESR1 and breast carcinoma.